MOTS Key Statistics, Chart & Performance
The current stock price of MOTS is 0.1735 USD. In the past month the price decreased by -72.53%. In the past year, price decreased by -98.67%.
MOTS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 218.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.09 | 207.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.1 | 144.75B | ||
| SYK | STRYKER CORP | 27.91 | 140.55B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| IDXX | IDEXX LABORATORIES INC | 56.57 | 56.96B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.02 | 39.76B | ||
| RMD | RESMED INC | 25.5 | 36.85B | ||
| DXCM | DEXCOM INC | 36.24 | 26.29B | ||
| PODD | INSULET CORP | 63.25 | 20.33B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.48 | 18.40B |
Related stock screener links
About MOTS
Company Profile
Motus GI Holdings Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Fort Lauderdale, Florida and currently employs 43 full-time employees. The company went IPO on 2018-02-14. Motus GI Holdings, Inc. is a medical technology company. The Company, through its subsidiaries in the United States and Israel, is engaged in providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions. The company has developed the Pure-Vu System, a medical device that helps to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. The Company’s wholly owned subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.
Company Info
MOTUS GI HOLDINGS INC
1301 E Broward Blvd Fl 3
FORT LAUDERDALE FLORIDA 33301 US
CEO: Timothy P. Moran
Employees: 43
Phone: 17864591831
MOTUS GI HOLDINGS INC / MOTS FAQ
What does MOTUS GI HOLDINGS INC do?
Motus GI Holdings Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Fort Lauderdale, Florida and currently employs 43 full-time employees. The company went IPO on 2018-02-14. Motus GI Holdings, Inc. is a medical technology company. The Company, through its subsidiaries in the United States and Israel, is engaged in providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions. The company has developed the Pure-Vu System, a medical device that helps to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. The Company’s wholly owned subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.
Can you provide the latest stock price for MOTUS GI HOLDINGS INC?
The current stock price of MOTS is 0.1735 USD. The price decreased by -34.06% in the last trading session.
What is the dividend status of MOTUS GI HOLDINGS INC?
MOTS does not pay a dividend.
How is the ChartMill rating for MOTUS GI HOLDINGS INC?
MOTS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for MOTS stock?
7 analysts have analysed MOTS and the average price target is 8.47 USD. This implies a price increase of 4779.54% is expected in the next year compared to the current price of 0.1735.
What is the next earnings date for MOTS stock?
MOTUS GI HOLDINGS INC (MOTS) will report earnings on 2024-05-08, after the market close.
MOTS Technical Analysis
MOTS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MOTS. MOTS may be in some trouble as it scores bad on both profitability and health.
MOTS Financial Highlights
Over the last trailing twelve months MOTS reported a non-GAAP Earnings per Share(EPS) of -28.56. The EPS increased by 68.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -178.25% | ||
| ROE | -479.16% | ||
| Debt/Equity | 0.46 |
MOTS Forecast & Estimates
7 analysts have analysed MOTS and the average price target is 8.47 USD. This implies a price increase of 4779.54% is expected in the next year compared to the current price of 0.1735.
For the next year, analysts expect an EPS growth of 58.34% and a revenue growth 337.5% for MOTS